Number of pages: 100-120 | Report Format: PDF | Published date: 20 July, 2022
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021 to 2031
The global bioreactor market was pegged at ~US$ 2.56 billion in 2021 and is expected to witness a CAGR of 16.0% during the forecast period.
Bioreactors are manufacturing systems or containers used to grow organisms such as yeast, bacteria, or animal cells in a controlled environment. They maintain a favorable environment for cell growth and product formation. Bioreactors are used in the pharmaceutical and biological industries to produce vaccines, antibodies, and biological products. They are also used in industrial processes to grow organisms under controlled conditions and to manufacture pharmaceuticals for chronic disease treatment. These devices control and monitor the environmental conditions throughout the culture's ongoing reaction. The precise design and selection of bioreactors are critical for achieving a high output. This, in turn, aids in obtaining the necessary capital investment and increases the economic viability of the bioprocess.
The advancement of bioreactor features and processing will aid in the growth of the bioreactor market. Manufacturers are constantly working to improve equipment to provide better control, ease of scaling up to process large volumes, and system simplification. Furthermore, advancements in design that allow for the cost-effective acceptance of single-use technologies would benefit business growth by providing benefits such as improved air and gas transfer efficiency, optimal cell mixing, and flexible operating conditions to maximize final outputs. Concerns about extractability affecting product quality and human health, on the other hand, would have a moderate impact on market growth during the forecast period.
The global bioreactor market has been analyzed from four perspectives: material type, usage, end user, and region.
Bioreactor Market by Material Type
Based on material type, the global bioreactor market has been segmented into glass, stainless steel, and single use. Single Use segment dominated the global bioreactor market and is expected to continue this trend during forecast period. The rapid adoption of single use technologies (SUTs) by industries is expected to drive future market growth. Single-use technology helps biopharmaceutical manufacturers eliminate the risk of contamination, which is the most difficult challenge for biopharmaceutical manufacturers, and increases operational efficiency by reducing or eliminating the need for sterilization between batches.
Bioreactor Market by Usage
Based on usage, the global bioreactor market has been classified into lab-scale production, pilot-scale production, and full-scale production. During the forecast period, the pilot-scale production segment dominated the market due to an increase in the prevalence of chronic disease, advancements in the pharmaceutical and biotechnology industries, and growth in the number of pre-clinical trials and clinical studies. However, the full-scale production segment is expected to grow significantly during the forecast period due to advancements in R&D activities for vaccine development and a surge in the adoption of advanced bioreactors.
Bioreactor Market by End User
On the basis of end user, the global bioreactor market has been segmented into pharmaceuticals and biopharmaceuticals manufactures, contract research organizations (CRO), academic & research institutes, and others. The pharmaceuticals and biopharmaceuticals manufactures segment dominated the global bioreactor market during the forecast period. A variety of pharmaceutical products are manufactured on an industrial scale through the bioprocessing of living cells. To drive high yield and productivity, traditional approaches are used to control various processes. Furthermore, monitoring and control of bioprocesses have become more complex as manufacturing processes have advanced, resulting in an increase in demand for advanced process control as well as the deployment of newer strategies for automation in the biopharmaceutical industry.
Bioreactor Market by Region
Based on the region, the global bioreactor market has been segmented into North America, Europe, Asia Pacific, and Rest of the World (RoW). North America dominated the bioreactors market and is expected to continue to do so during the forecast period owing to the rise in the number of academic institutes in countries in the region and expanding R&D facilities. Moreover, Asia Pacific is projected to register a rapid revenue over the forecast period. The rapid increase in population and the rising prevalence of chronic diseases are major factors driving pharmaceutical manufacturing. Rapid growth in the pharmaceutical industry in the region due to the availability of low-cost Active Pharmaceutical Ingredients (API) and labor, thus increasing the demand for bioreactors and fermenters for drug development.
Some of the key players operating the global bioreactor market are
To gain a strong position in the market, these key players are pursuing various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures.